NCCN Guidelines Version 2.2023
- Esophageal and Esophagogastric Junction Cancers
NCCN Guidelines with Evidence Blocks Version 2.2023
Basic Resources (English) Version 3.2022 (Preliminary)
Core Resources (English) Version 3.2022 (Preliminary)
Enhanced Resources (English) Version 3.2022 (Preliminary)
Esophageal Cancer-English Version 2022
Calendar of Events
Continuing Education
Recorded Presentation from the NCCN Pharmacy Updates: Navigating Advances in Targeted Therapies for Advanced Esophageal, Esophagogastric Junction (EGJ) and Gastric Cancers
Archived Monthly Oncology Tumor Boards: Esophageal and Esophagogastric Junction Cancers: Postoperative Therapy in Patients with Residual Disease
Translations
Chinese Version 3.2022
Harmonized
English (Africa) Version 4.2020
Disclosure Policy
Panel Member Disclosures
Panel Member Disclosures by Meeting Date
End User License Agreement